USPTO serial 79018321
NHWA
Reviewed by CopyMark Law Group
Reg. 3206407Status 404
- Filing date
- Status date
- Registration date
- Feb 6, 2007
- Examiner
- EVANKO, PATRICIA MALESARDI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NHWA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human use and Chemico-pharmaceutical preparations, namely pharmaceutical preparations used to diminish inflammation, ease pain, relieve itch, allay a fever, stop bleeding, reduce tumefaction, dissolve gore; pharmaceutical preparations in the treatment of diseases caused by influenza, spasm, pain, hypomnesis, hindrance in the function of brain function, hindrance in upgrowth, ischemia and vasospasm; pharmaceutical preparations in the treatment of diseases caused by rheumatism; pharmaceutical preparations in the treatment of disorder in blood-lipid and blood pressure, convulsion, epilepsy, dementia, depression, mania, anxiety, hallucination, ataxia, constrain, schizophrenia, mental diseases, psychonosema, tremor, hypersensitivity, restlessness, scurvy, diabetes, obesity, neuropathy, psychoneurosis, neuronal diseases, parasitosis, heart attack, dermatosis, ophthalmopathy, otopathy, rhinopathy, laryngopathy, diseases in brain, diseases in lung, diseases in intestinal canal, diseases in stomach, diseases in liver, diseases in biliary tract, diseases in kidney, diseases in womb, cancer, stomatopathy, gynecological diseases, obstetrical diseases, angionosis, diseases in skeleton and bones, diseases in muscle, hematopathy, endocrinopathic diseases, diseases in urogenital system, diseases in genital system, respiratory failure, vomit; immuno-modulators; central nerve stimulants; hypnotics, sedatives, antithrombotics; pharmaceutical preparations in the treatment of lack of inorganic salts, sprain, wounds, debility, apoplexy, heatstroke; antidotes; anti-senile agents; Sanitary sterilizing preparations; medicinal herbs in dried or preserved form; ointment for pharmaceutical purposes, namely disinfectant ointments, antibacterial ointments, anti-inflammatory ointments, burn treatment ointments, analgesic ointments, antipruritic ointments; Isopropyl alcohol for medical use; Traditional Chinese medicines for the treatment to diminish inflammation, ease pain, relieve itch, allay a fever, stop bleeding, reduce tumefaction, dissolve gore; Traditional Chinese medicines for the treatment of diseases caused by influenza, spasm, pain, hypomnesis, hindrance in the function of brain function, hindrance in upgrowth, ischemia and vasospasm; Traditional Chinese medicines for the treatment of diseases caused by rheumatism; Traditional Chinese medicines for the treatment of disorder in blood-lipid and blood pressure, convulsion, epilepsy, dementia, depression, mania, anxiety, hallucination, ataxia, constrain, schizophrenia, mental diseases, psychonosema, tremor, hypersensitivity, restlessness, scurvy, diabetes, obesity, neuropathy, psychoneurosis, neuronal diseases, parasitosis, heart attack, dermatosis, ophthalmopathy, otopathy, rhinopathy, laryngopathy, diseases in brain, diseases in lung, diseases in intestinal canal, diseases in stomach, diseases in liver, diseases in biliary tract, diseases in kidney, diseases in womb, cancer, stomatopathy, gynecological diseases, obstetrical diseases, angionosis, diseases in skeleton and bones, diseases in muscle, hematopathy, endocrinopathic diseases, diseases in urogenital system, diseases in genital system, respiratory failure, vomit; immuno-modulators; central nerve stimulants; hypnotics, sedatives, antithrombotics; Traditional Chinese medicines for the treatment of lack of inorganic salts, sprain, wounds, debility, apoplexy, heatstroke; antidotes; anti-senile agents; Sanitary sterilizing preparations; Alcohols for pharmaceutical purposes, namely alcohols for the treatment of diseases caused by rheumatism, arthritis, diseases in lung, diseases in intestinal canal, diseases in stomach, diseases in liver, diseases in biliary tract, diseases in kidney, cancer, stomatopathy, gynecological diseases, angionosis, diseases in skeleton and bones, diseases in muscle, diseases in urogenital system, immuno-modulators;dietetic foods adapted for medical use | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NHWA PHARMACEUTICAL CORPORATION
- Other trademarks owned by NHWA PHARMACEUTICAL CORPORATION
- Other trademarks owned by NHWA PHARMACEUTICAL CORPORATION
- Other trademarks in Class 005
- Similar marks named NHWA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 29, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 24, 2015 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Sep 24, 2015 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Feb 6, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 6, 2014 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Dec 6, 2014 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jun 4, 2014 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 4, 2013 | C71T | CANCELLED SECTION 71 | — |
| May 23, 2008 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 28, 2007 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 28, 2007 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 23, 2007 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 6, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 21, 2006 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 1, 2006 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 28, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 26, 2006 | ALIE | ASSIGNED TO LIE | — |
| Sep 15, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 25, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 21, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 17, 2006 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 17, 2006 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 9, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| May 2, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 28, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 28, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 27, 2006 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 9, 2006 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 30, 2005 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 29, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 27, 2005 | NWAP | NEW APPLICATION ENTERED | — |
| Dec 22, 2005 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |